Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells

Abstract

clonotypes), which are primed against high-affinity antigens and maintain waves of effector TRM-like cells. Our results define the signature of relevant tumor-reactive T cells in human ovarian cancer, which could be applicable to other tumors with unideal mutational burden.